Skip to main content
. Author manuscript; available in PMC: 2010 Jul 29.
Published in final edited form as: Appl Health Econ Health Policy. 2009;7(4):229–243. doi: 10.2165/11318740-000000000-00000

Table 2.

HBAC HAART program: Incremental costs, benefits and cost-effectiveness results over two years.

Costs, health benefits and cost-effectiveness
Program cost for 1,000 clients $1,386,670
Cost of ART for deaths prevented $3,634,353
Program cost plus costs of HAART for deaths prevented in first two years $5,021,023
Savings in opportunistic infection treatment costs ($247,750)
Cost net of opportunistic HIV infections prevented $4,773,273
Savings in new infant and adult HIV cases prevented ($677,815)
Cost net of illness and new adult and infant HIV infections prevented $4,095,458

DALYs averted (deaths and infections prevented; incl. deaths prevented in HIV-neg. children) 6,791
DALYs averted through MTCT 70
Total DALYs averted 6,861

Net cost per DALY averted $597